Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divalent cations such as calcium (Ca²⁺), magnesium (Mg²⁺), zinc (Zn²⁺), iron (Fe²⁺), barium (Ba²⁺), and manganese (Mn²⁺) are not proteins, receptors, or enzymes but are inorganic ions that play essential structural roles in the stabilization of bacterial biofilm matrices. They interact electrostatically with negatively charged polymers (notably extracellular DNA and exopolysaccharides) within the biofilm, enhancing its integrity and mechanical stiffness. Removal or chelation of these cations disrupts the matrix and can increase biofilm susceptibility to antimicrobials. Divalent cations are crucial for the cohesion, structure, and resistance properties of biofilms formed by both Gram-positive (e.g., *Streptococcus mutans*) and Gram-negative (e.g., *Pseudomonas aeruginosa*) bacteria. Their effect can be species- and ion-specific. Chelating agents like EDTA may be used experimentally or therapeutically to destabilize biofilms by sequestering matrix-stabilizing cations, but this approach is not highly targeted and carries risks due to the importance of divalent cations in host physiology. "Divalent cations in bacterial biofilm matrix" as written does not correspond to a specific molecular target for therapeutics (such as a receptor, enzyme, or transporter), but rather to a class of ions with a collective structural effect on the microbial biofilm environment. Thus, this query does not represent a canonical drug target suitable for structured therapeutic targeting.
Matrix destabilization by chelation (for agents like EDTA that remove divalent cations), Inhibition of biofilm formation/stability
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divalent cation in bacterial biofilm matrix.